19.03.2026 06:00 | NY Times World
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
🔗 Citește articolul complet pe NY Times World18.10.2026 13:20 | Fanatik
18.10.2026 13:19 | DigiSport
18.10.2026 13:12 | DigiSport
18.10.2026 13:06 | DigiSport
18.10.2026 13:02 | Prosport
18.10.2026 13:00 | Fanatik